JONES FINANCIAL COMPANIES LLLP

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 815917 DES PERES, MO

Back to TEVA Full portfolio

Position in TEVA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$9,675,116

+$9,123,199 QoQ

Shares Held

321,219

+1716.4% QoQ

Ownership

0.028%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

9 quarters on record

Voting authority Sole 99.49318066490463.ToString("F0")% Shared 0.ToString("F0")% None 0.5068193350953711.ToString("F0")%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

JONES FINANCIAL COMPANIES LLLP holds $151,859,373 across 48 Drug Manufacturers - Specialty & Generic names. TEVA ranks #4 (6.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HLN	Haleon plc	9,086,528	$90,956,145
2	ZTS	Zoetis Inc.	179,646	$21,235,953
3	PBH	Prestige Consumer Healthcare Inc.	250,151	$14,826,449
4	TEVA	Teva Pharmaceutical Industries Ltd This page	321,219	$9,675,116
5	ESPR	Esperion Therapeutics, Inc.	2,135,741	$5,851,930
6	NBIX	Neurocrine Biosciences Inc	23,151	$3,049,911
7	UTHR	UNITED THERAPEUTICS Corp	2,960	$1,755,220
8	AMRX	Amneal Pharmaceuticals, Inc.	54,322	$675,222

All Filings in TEVA

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,675,116	321,219	+1716.4%	Shares	Sole	2026-05-15
2025-12-31	$551,917	17,684	+17.2%	Shares	Sole	2026-02-17
2025-09-30	$304,737	15,086	+44.4%	Shares	Sole	2025-11-04
2025-06-30	$175,125	10,449	-9.4%	Shares	Sole	2025-08-13
2025-03-31	$177,308	11,536	+34.3%	Shares	Sole	2025-05-28
2024-12-31	$189,367	8,592	+145.4%	Shares	Sole	2025-02-06
2024-09-30	$63,088	3,501	+3172.0%	Shares	Sole	2024-11-12
2024-06-30	$1,738	107	-46.5%	Shares	Sole	2024-08-14
2023-03-31	$1,770	200	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.